Active Ingredient: BIVALIRUDIN
Proprietary Name: BIVALIRUDIN
Dosage Form; Route of Administration: INJECTABLE; INTRAVENOUS
Strength: 250MG/VIAL
Reference Listed Drug: No
Reference Standard: No
TE Code: AP
Application Number: A091602
Product Number: 001
Approval Date: Jul 16, 2018
Applicant Holder Full Name: MEITHEAL PHARMACEUTICALS INC
Marketing Status:
Prescription
Patent and Exclusivity Information